Table 1.
The inhibition rates of TSWV with treatment by different compounds.
| Compound name | Inhibitor rate (%) | Compound name | Inhibitor rate (%) | ||
|---|---|---|---|---|---|
| Protection | Curation | Protection | Curation | ||
| Compound1 | 56.50 ± 1.90b | 54.80 ± 0.70b | Compound16 | 66.30 ± 0.70b | 61.60 ± 0.60b |
| Compound2 | 53.30 ± 0.90b | 45.80 ± 0.30b | Compound18 | 57.20 ± 2.80b | 47.80 ± 3.10b |
| Compound3 | 58.10 ± 0.40b | 46.30 ± 0.20b | Compound20 | 76.50 ± 0.40b | 62.40 ± 1.70b |
| Compound6 | 58.80 ± 1.10a | 56.00 ± 0.70a | Compound22 | 60.50 ± 0.40a | 52.10 ± 1.20b |
| Compound7 | 54.80 ± 0.70b | 52.40 ± 1.60b | Compound25 | 63.20 ± 1.60a | 61.30 ± 2.10b |
| Compound8 | 54.40 ± 0.70b | 60.80 ± 1.30a | Compound27 | 67.10 ± 0.20b | 62.20 ± 0.20b |
| Compound9 | 50.00 ± 0.40b | 61.90 ± 1.60b | Compound28 | 69.50 ± 0.60b | 61.90 ± 0.30b |
| Compound13 | 58.4 ± 0.90a | 60.30 ± 1.10b | Ningnanmycin | 61.25 ± 0.70a | 58.80 ± 1.30a |
Different letters indicate significant differences for different compounds compared with ningnanmycin; differences are significant at P ≤ 0.05.